ChemImpex Tobramycin; 900 µg/mg (HPLC); 32986-56-4; MFCD00077885, 5G

Tobramycin is a potent aminoglycoside antibiotic widely utilized in the treatment of various bacterial infections, particularly those caused by Gram-negative bacteria. Its unique mechanism of action involves inhibiting protein synthesis in bacteria, making it an essential choice in clinical settings, especially for patients with cystic fibrosis who are at risk of Pseudomonas aeruginosa infections. Tobramycin is often administered via inhalation or injection, providing targeted therapy that maximizes efficacy while minimizing systemic exposure.

In addition to its therapeutic applications, Tobramycin is also valuable in research settings, where it is used to study bacterial resistance mechanisms and the pharmacokinetics of aminoglycosides. Its effectiveness against resistant strains makes it a critical component in the development of new treatment protocols. Researchers and healthcare professionals appreciate Tobramycin for its reliability and the significant role it plays in combating serious infections, thus enhancing patient outcomes and advancing medical science.

Specifications

Safety & Regulations